Caring for a Loved One with CCA: A Son’s Perspective

June/July 2022, Vol 3, No 2

At the 2022 Cholangiocarcinoma Foundation annual meeting, Ambuj Srivastava shared his experience as a current caregiver for his dad who was diagnosed with stage 2 extrahepatic cholangiocarcinoma (CCA). Ambuj lives in Toronto, Canada, with his wife, daughter, and parents. He is a mentee and patient advocate with the Cholangiocarcinoma Foundation.

Following a diagnosis of stage 2 extrahepatic CCA in September 2019, Ambuj’s father underwent surgery, chemotherapy, and immunotherapy. During that time, he “dealt with many monthly ER visits to the hospital due to blockages or infections.”

Ambuj described the initial days following his father’s diagnosis. “I was multitasking at work and home, talking to multiple specialists, coordinating meetings. There was a whole lot of information to process, stress, anxiety, confusion—it all became quite challenging,” Ambuj said. “We went through a rollercoaster of emotions. It was difficult and caused many restless nights.”

According to Ambuj, the caregiver role is a dynamic one, encompassing caregiving, care living, and care loving:

  • Caregiving is “a privilege for providing or taking care of a loved one during their most precious and maybe limited moments.”
  • Care living is “changing lifestyle, expectations, and boundaries for what you can and cannot do.”
  • Care loving is “self-care, which is usually given the least priority, but it is the glue that will keep you and your responsibilities together with a good support system in place.”

The biggest role is to advocate for the needs of the loved one, according to Ambuj. “It’s important to ensure that your loved one feels like they are in control of their health decisions,” he said. “Empower them to speak up and voice their concerns.”

Ambuj shared some pearls of wisdom that have helped him navigate his caregiving journey:

  • Define limits. Caregiving is a priority and balancing act that can become challenging. His advice: Plan for 1 day at a time.
  • Create a support system. This could include family, friends, support groups, managers, coworkers, mentors, social workers, and palliative support personnel—anyone who can provide physical and emotional assistance. Palliative support is important and does not necessarily mean the end of the road; it can provide many benefits to patients and their families.
  • Avoid caregiver burnout by assessing and managing with an appropriate support system.
  • Adopt the right mindset because “the first line of treatment is attitude.”

Ambuj recounted how his initial thinking about caregiving changed drastically after this experience. “I thought it was something that you would do for your loved one without any titles or any expressions or words,” he said. “But I now understand the importance of verbalizing and acknowledging the role of a caregiver.”

Ambuj concluded by saying, “Caregivers are like sidekicks to the real superheroes of this journey, Robin to the Batman. Superheroes are cool but I think sidekicks are pretty badass, too.”

Related Items

Biomarker Discovery and Early Detection in CCA
June 2025, Vol 6, No 2
Experts unveiled a roadmap for translating cutting-edge biomarkers into clinical practice, paving the way for improved early detection and personalized care in high-risk populations with cholangiocarcinoma (CCA).
Translational Science and Discovery in CCA
June 2025, Vol 6, No 2
Leading experts explored groundbreaking advancements in tumor microenvironments, biomarker validation, and innovative therapies, paving the way for transformative precision medicine in cholangiocarcinoma (CCA) care.
Advancements in Cholangiocarcinoma Diagnosis and Treatment: Radiomics, Biomarkers, and Optimal Biliary Decompression
June 2025, Vol 6, No 2
Cutting-edge advancements in tumor microenvironments, therapeutic resistance, biomarker validation, and innovative treatments are paving the way for breakthroughs in precision medicine.
Pathology in CCA
June 2025, Vol 6, No 2
Experts in cholangiocarcinoma (CCA) have explored the transformative role of artificial intelligence in improving CCA diagnosis, predictive marker identification, and understanding precursor lesions to advance targeted therapies and personalized care.
Locoregional Therapies and Radiation for the Treatment of Patients With CCA
June 2025, Vol 6, No 2
Experts have highlighted the latest advancements in locoregional treatments, including hepatic arterial infusion, selective internal radiation therapy, ablation techniques, and histotripsy, offering new hope for improving survival in cholangiocarcinoma (CCA) patients.
Systemic Therapies and Surgery for CCA
June 2025, Vol 6, No 2
Experts discuss advancements in systemic therapies, surgical strategies, and liver transplantation, offering new hope for improving outcomes in patients with cholangiocarcinoma (CCA).
Tinengotinib: A Next-Generation Fibroblast Growth Factor Receptor (FGFR) Inhibitor for CCA
June 2025, Vol 6, No 2
Tinengotinib emerged as a promising next-generation multikinase inhibitor, offering new hope for patients with resistant cholangiocarcinoma (CCA) through its innovative mechanism of action and encouraging clinical trial results.
Advancing Oncology Research Through Novel Endpoints and Consensus-Driven Collaboration
June 2025, Vol 6, No 2
A collaborative roadmap has been unveiled to redefine clinical endpoints, advance precision medicine, and align global efforts in tackling the challenges of rare and aggressive biliary tract cancers.
AI-Driven Approaches in CCA
June 2024, Vol 5, No 2
Three presentations discussed the application of artificial intelligence learning– and machine learning-driven approaches to improve pathology, radiology, and drug discovery processes, showing strong potential for improving outcomes in patients with cholangiocarcinoma.
Cancer Vaccines Targeting WT1 for CCA
June 2024, Vol 5, No 2
Benjamin L. Green, MD, presented Wilms’ tumor 1 vaccine novel adoptive cell therapy approaches for advanced solid cancers, including the role of immunotherapy in treating advanced cholangiocarcinoma.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State